In Vitro Models of Sturge–Weber Syndrome: Strengths, Limitations, and Future Goals
International Journal of Molecular Sciences · 03.05.2026 · 27 (9) · 4100
DOI: 10.3390/ijms27094100 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.05.2026. Verfasst von Ashleigh B Manney und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurodevelopmental Medicine, Kennedy Krieger Institute, Baltimore, MD 21205, USA. Hauptthemen laut MEDLINE: Sturge-Weber Syndrome. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faneca 66 Foundation.
Abstract (Originalsprache)
Sturge–Weber Syndrome (SWS) is a rare congenital disorder presenting with a vascular malformation in the upper face and brain, causing impaired blood–brain barrier function and perfusion, increased calcium signaling, inflammation, and seizures. All these neuropathologic processes result in injury to the brain. The somatic GNAQ R183Q variant, which accounts for the majority of SWS cases, increases signaling through MAPK, PI3K, mTOR, and inflammatory pathways, primarily in endothelial cells. The discovery of this variant enabled the creation of transgenic and genetic animal and cell culture models. Generating in vitro models has been challenging due to the mosaic nature of SWS, and attempts to separate unaffected from mutant cells in primary culture have failed, limiting the utility of in vitro work. Ongoing in vitro work seeks to overcome these limitations, shape our understanding of SWS, and lead to translational advances in treatment and prevention by studying the affected molecular pathways and identifying future targets for therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurodevelopmental Medicine, Kennedy Krieger Institute, Baltimore, MD 21205, USA.
- Hunter Nelson Sturge-Weber Syndrome Center, Kennedy Krieger Institute, Baltimore, MD 21205, USA.
- Moser Center for Leukodystrophies, Kennedy Krieger Institute, Baltimore, MD 21205, USA.
- Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.
- Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.
Förderung
- Faneca 66 Foundation
Zitieren
APA
Manney, A. B., Nemeth, C. L., & Comi, A. M. (2026). In Vitro Models of Sturge–Weber Syndrome: Strengths, Limitations, and Future Goals. International Journal of Molecular Sciences, 27(9), 4100. https://doi.org/10.3390/ijms27094100
Vancouver
Manney AB, Nemeth CL, Comi AM. In Vitro Models of Sturge–Weber Syndrome: Strengths, Limitations, and Future Goals. International Journal of Molecular Sciences. 2026;27(9):4100. doi:10.3390/ijms27094100
BibTeX
@article{Manney2026,
author = {Manney, Ashleigh B and Nemeth, Christina L and Comi, Anne M},
title = {In Vitro Models of Sturge–Weber Syndrome: Strengths, Limitations, and Future Goals},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {9},
pages = {4100},
doi = {10.3390/ijms27094100}
}
EUVIMED